@napdicenter

napdicenter has been a member of Linktree for 3 years and joined in February 2023. The social media accounts linked to from napdicenter are: • Facebook • Instagram • X Besides social media accounts, napdicenter has populated their site with: • NEED SUBJECTS - Kratom-Drug Interaction Study - Spokane, WA • Translating Kratom-Drug Interactions: From Bedside to Bench and Back • Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug Associated Acute Kidney Injury (D-AKI) in Retrospective, Observational Studies • Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries • Impact of drug-mediated inhibition of intestinal transporters • Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in Mice • Assessment of Orally Administered Δ9-THC When Coadministered With CBD • Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom • Developing a Knowledge Graph for Pharmacokinetic NPDIs • Limitations of fexofenadine limited sampling strategy using plasma concentrations • An evaluation of adverse drug reactions and outcomes attributed to kratom • A Physiologically-Based Pharmacokinetic Model for Cannabidiol • Broadening the capture of NPs mentioned in FAERS • FDA issues another kratom warning following death • Coleus (Coleus forskholii) Coleus stem extract Nuclear Receptor Induction study - Ole Miss studies • Cat's-claw (Uncaria tomentosa) Identification of PXR activators from Uncaria tomentosa (Cat’s Claw) studies • Gou Teng (Uncaria rhynchophylla) Identification of PXR activators from Uncaria rhynchophylla (Gou Teng) studies • Goldenseal (Hydrastis canadensis) R21 Goldenseal Project Studies • UNCG Honored for its Inclusive 'Chemistry' - UNC Greensboro • Seeking healthy subjects for a botanical-drug interaction study • Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective • Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants • Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach • Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products • A Case of Potential Pharmacokinetic Kratom-drug... : Journal of Addiction Medicine • Comprehensive Predictions of Cytochrome P450 (P450)-Mediated In Vivo Cannabinoid-Drug Interactions Based on Reversible and Time-Dependent P450 Inhibition in Human Liver Microsomes • Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom - PubMed • Developing a Knowledge Graph for Pharmacokinetic Natural Product-Drug Interactions • Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults - PubMed • An evaluation of adverse drug reactions and outcomes attributed to kratom in the US Food and Drug Administration Adverse Event Reporting System from January 2004 through September 2021 • Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2 • A Physiologically-Based Pharmacokinetic Model for Cannabidiol in Healthy Adults, Hepatically-Impaired Adults, and Children • 650: Dr. Nicholas Oberlies: Finding Compounds in Fungi to Develop New Drugs to Fight Cancer - People Behind the Science Podcast • Hierarchical cluster analysis of technical replicates to identify interferents in untargeted mass spectrometry metabolomics • 2022-2023 Gateway Research Awar • Winners of the 2020 JA Ōmura Awards for excellence - The Journal of Antibiotics • Fabulous fungi and pharmacognosy with Dr. Nicholas Oberlies • Indinavir Increases Midazolam N-Glucuronidation in Humans: Identification of an Alternate CYP3A Inhibitor Using an In Vitro to In Vivo Approach • Capturing the Complex Interplay Between Drugs and the Intestinal Microbiome • Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis • Quantifying Hepatic Enzyme Kinetics of (-)-∆9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, 11-OH-THC, through In Vitro Modeling • Assessing Transporter-Mediated Natural Product-Drug Interactions Via In vitro-In Vivo Extrapolation • Certain foods and beverages can interact with drugs • Chemical composition and biological effects of kratom • Thummel and Paine share thoughts on the importance of mentorship through DMDD • Herbal Remedies | Chimikos Consulting | Nicholas H. Oberlies • Center of Excellence for Natural Product-Drug Interaction Research (NaPDI) • Oberlies Research Group | UNCG • Paine Research Group | WSU Pharmacy • Cech Research Group | UNCG